Bank of America began coverage on shares of Xencor (NASDAQ:XNCR – Get Rating) in a research report report published on Friday, The Fly reports. The firm issued a buy rating and a $42.00 target price on the biopharmaceutical company’s stock. Several other research firms also recently weighed in on XNCR. SVB Leerink reiterated an outperform […]
Shares of Xencor, Inc. (NASDAQ:XNCR – Get Rating) have earned a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the […]
Xencor, Inc. (NASDAQ:XNCR – Get Rating) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $31.40 and traded as low as $27.92. Xencor shares last traded at $28.67, with a volume of 439,389 shares trading hands. Analysts Set New Price Targets XNCR has […]
Assenagon Asset Management S.A. reduced its stake in shares of Xencor, Inc. (NASDAQ:XNCR – Get Rating) by 8.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,901 shares of the biopharmaceutical company’s stock after selling 4,086 shares during […]
Shares of Xencor, Inc. (NASDAQ:XNCR – Get Rating) crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $31.86 and traded as low as $27.81. Xencor shares last traded at $28.12, with a volume of 264,387 shares traded. Analysts Set New Price Targets A number of […]